Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term immunity of IXIARO in pediatric population
NCT01246479Phase 3Completed
- Sponsor
- Valneva
- Start
- Oct 2010
- Primary completion
- Oct 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 3 trial of Japanese encephalitis inactivated vaccine in Japanese encephalitis (JE), sponsored by Valneva. Started Oct 2010; status: completed.
02
Drugs
Japanese encephalitis inactivated vaccine
03
Conditions
Japanese encephalitis (JE)
Beyond the preview
Go deeper on NCT01246479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01246479.